Pharmaceutical company Novartis announced Tuesday that its eye care division, Alcon, will license Google’s smart contact lens technology, creating a tool to monitor diabetics’ blood sugar levels through tear samples, Time.com reports.
Alcon will collaborate with Google[x], Google’s secretive lab for major technological advances which also designed Google Glass. The two will join forces to develop contact lenses that wirelessly connect to mobile devices to report blood sugar in near-real-time. The technology may also provide accommodative vision correction for those with impaired eyesight.
See this story on time.com